Add BrightSurf on Google Email

AI algorithm can help identify high-risk heart patients to quickly diagnose, expedite, and improve care

A new AI algorithm, Viz HCM, can quickly and specifically identify high-risk heart patients with hypertrophic cardiomyopathy (HCM) and provide individualized risk assessments. The algorithm's findings can help doctors prioritize the highest-risk patients for earlier appointments and treatment.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNEJM AI·TypeData/statistical analysis·DateApr 24, 2025

Simple consultations in emergency room can help patients manage high blood pressure

A study from the University of Illinois Chicago found that simple consultations during emergency room visits can significantly lower blood pressures and improve hypertension management. The intervention, which included smartphone-paired blood pressure monitors, was particularly effective for patients from underrepresented backgrounds, ...

SourceUniversity of Illinois Chicago·JournalJAMA Cardiology·DateApr 24, 2025

AI algorithm can help identify high-risk heart patients to quickly diagnose, expedite, and improve care

A new AI algorithm has been calibrated to quickly identify patients with hypertrophic cardiomyopathy (HCM) and provide individualized risk assessments. The tool can help prioritize high-risk patients for earlier appointments and treatment, leading to better patient outcomes.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNEJM AI·TypeData/statistical analysis·DateApr 22, 2025

Combination of drugs could prevent thousands of heart attacks

A new study suggests that treating patients earlier with a combination of statins and ezetimibe could prevent thousands of new heart attacks over a decade. By lowering LDL or 'bad' cholesterol in the blood, this treatment strategy can stabilise changes in the vessels and decrease the risk of new events.

SourceImperial College London·JournalJournal of the American College of Cardiology·TypeComputational simulation/modeling·DateApr 14, 2025

Breakthrough research revolutionizing pulmonary hypertension treatment

A recent study published in the International Journal of Cardiology analyzed data from multiple clinical trials to assess the therapeutic impact of pulmonary artery denervation (PADN) on pulmonary hypertension patients. PADN showed significant reductions in mean right atrial pressure, mean pulmonary artery pressure, and pulmonary vascu...

SourceOchsner Health System·JournalInternational Journal of Cardiology·DateApr 8, 2025

Handheld device could transform heart disease screening

Researchers at the University of Cambridge have developed a handheld device that can accurately record heart sounds without requiring precise placement on the chest. This innovative device, which uses six sensors to capture clearer heart sounds, has the potential to transform heart disease screening and diagnosis.

SourceUniversity of Cambridge·JournalIEEE Journal of Biomedical and Health Informatics·DateApr 8, 2025

Clinical trial shows electronic provider notifications can improve rates of treatment for valvular heart disease

A clinical trial found that electronic messages sent to providers improved care for patients with severe aortic stenosis, including higher rates of treatment with valve replacement. The study also showed improved survival for patients in the notification group, with an average increase of 12 days.

SourceMass General Brigham·JournalCirculation·TypeRandomized controlled/clinical trial·DateApr 1, 2025

People with heart failure can safely drink fluids without restrictions

A large-scale study found that limiting fluid intake in patients with stable heart failure has no health benefits and may even cause increased thirst. Conversely, drinking more fluids without restriction did not lead to any negative outcomes, suggesting that fluid restrictions are unnecessary for these patients.

SourceRadboud University Medical Center·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateMar 30, 2025

Groundbreaking consensus statement on conduction system pacing released: a major milestone in the evolution of pacing therapy

The European Society of Cardiology has released a groundbreaking consensus statement on conduction system pacing, offering updated guidance for healthcare professionals on selecting patients. Conduction system pacing is being increasingly adopted due to its perceived ease of implantation and superior electrical performance.

SourceEuropean Society of Cardiology·JournalEP Europace·DateMar 29, 2025

Dapagliflozin safe and effective in elderly patients with heart failure undergoing valve replacement

A study presented at the American College of Cardiology's Annual Scientific Session found that dapagliflozin significantly reduced the rate of worsening heart failure in elderly patients with heart failure undergoing transcatheter aortic valve replacement. The trial, called DapaTAVI, enrolled 1,257 patients and showed a 28% lower rate ...

SourceAmerican College of Cardiology·JournalNew England Journal of Medicine·DateMar 29, 2025

Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

A new clinical trial found that oral semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease. The medication decreased the risk of major cardiac events by 14% compared to placebo, with nonfatal myocardial infarction seeing the greatest reductions in risk.

SourceUniversity of North Carolina Health Care·JournalNew England Journal of Medicine·DateMar 29, 2025

American College of Cardiology recognizes three recipients of the Hani Najm Global Scholar Award Observership Program

The American College of Cardiology will honor three early career cardiologists with the Hani Najm Global Scholar Award Observership Program at ACC.25, taking place in Chicago. The program encourages international cardiology professionals to share knowledge and enhance their training by shadowing a practicing cardiologist in the US.

Daily sedentary behavior and physical activity are associated with exercise capacity in adult patients with congenital heart disease

Adult patients with congenital heart disease have poor exercise capacity due to increased sedentary behavior. Increasing moderate-to-vigorous physical activity for 10 minutes daily can boost peak oxygen uptake by up to 0.454 mL/min/kg, suggesting a positive impact on prognosis and mobility.

SourceUniversity of Tsukuba·JournalInternational Journal of Cardiology Congenital Heart Disease·DateMar 24, 2025

E-cigarettes linked to lower cardiac risks compared to tobacco cigarettes in people with HIV

Researchers found that electronic cigarettes have a lower likelihood of causing changes associated with atherogenesis, compared to tobacco cigarettes, among people living with HIV. This suggests switching to e-cigarettes could be a promising harm reduction strategy for this vulnerable population.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of the American Heart Association·TypeRandomized controlled/clinical trial·DateMar 19, 2025

JSCAI special issue explores the transformative role of artificial intelligence in interventional cardiology

This special issue explores AI's applications across various subspecialties, including coronary interventions, structural heart disease, and cardiovascular imaging. It highlights the importance of responsible AI integration and addressing bias in decision support systems.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateMar 18, 2025